Stocktoria
Surgery Partners, Inc. SGRY
Surgery Partners, Inc. (SGRY) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $3.3B at a -2.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.066 |
| Retained earnings / assets | -0.1 |
| EBIT / assets | 0.048 |
| Equity / liabilities | 0.628 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SGRY | Surgery Partners, Inc. | 5/9 | 1.09 | — | +6.2% |
| ARDT | Ardent Health, Inc. | 5/9 | — | 10.3 | +6% |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 8/9 | 0.28 | 0.9 | -1.2% |
| UHS | UNIVERSAL HEALTH SERVICES INC | 7/9 | 3.55 | 5.9 | +9.7% |
| THC | TENET HEALTHCARE CORP | 3/9 | 2.33 | — | +3.1% |
| HCA | HCA Healthcare, Inc. | 6/9 | — | 12.8 | +7.1% |
| GOOG | Alphabet Inc. | 5/9 | 6.79 | 31.1 | +15.1% |
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
FAQ
Is SGRY financially healthy?
Surgery Partners, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does SGRY pay a dividend?
No, Surgery Partners, Inc. does not currently pay a dividend.
How profitable is SGRY?
In FY2025, Surgery Partners, Inc. had a net margin of -2.4% and a return on equity of -2.5%.
What is the analyst price target for SGRY?
The average Wall-Street price target for Surgery Partners, Inc. is $17.95, about 17.2% above the recent price, from 11 analysts.
Is SGRY a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Surgery Partners, Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.